Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aihua Zhang
Peking University Third Hospital
Principal Investigator - Aili Jiang
Tianjin Medical University Second Hospital
Principal Investigator - Chaosheng Chen
First Affiliated Hospital of Wenzhou Medical University
Principal Investigator - Guanqing Xiao
First People's Hospital of Foshan
Principal Investigator - Guohua Ding
Hubei General Hospital
Principal Investigator - Hong Liu
Second Xiangya Hospital of Central South University
Principal Investigator - Jianming Ye
The First People's Hospital of Kunshan
Principal Investigator - Jianying Niu
Fudan University
Principal Investigator - Jiazhuang Lou
The First Affiliated Hospital with Nanjing Medical University
Principal Investigator - Junwei Yang
Second Affiliated Hospital of Nanjing Medical University
Principal Investigator - Li Hao
The Second Hospital of Anhui Medial University
Principal Investigator - Li Zuo
Peking University People's Hospital
Principal Investigator - Ping Fu
West China Hopsital, Sichuan University
Principal Investigator - Qiang He
Sichuan Provincial People's Hospital
Principal Investigator - Shixiang Wang
Beijing Chao Yang Hospital
Principal Investigator - Xiaonong Chen
Ruijin Hospital
Principal Investigator - Xuemei Li
Peking Union Medical College Hospital
Principal Investigator - Yisheng Ling
Zhongshan Hospital Xiamen University
Principal Investigator - Yonghui Mao
Beijing Hospital
Principal Investigator - Zhangsuo Liu
The First Affiliated Hospital of Zhengzhou University
Principal Investigator - Zhaohui Ni
RenJi Hospital
Principal Investigator - Zhihong Liu
Jinling Hospital, China
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Nanjing Jinling Hospital
Nanjing, Jiangsu, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Apr 2017
- Primary completion
- 20 Apr 2019
- Completion
- 6 Sept 2019
- Last update posted
- 29 Apr 2024
- Registered enrollment
- 750
- Registry id
- NCT03123406
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.